Tyler Wagner, PhD

Dr. Tyler Wagner serves as Vice President of Biomedical Research at Anumana, where he leads efforts to harness artificial intelligence for earlier disease detection and therapeutic intervention. At Anumana, Dr. Wagner is at the forefront of applying machine learning to difficult to diagnose conditions, where AI-empowered solutions can have a significant impact. His work spans early development to clinical study design and implementation of ECG-AI.

Dr. Wagner has been with Anumana since its inception and previously worked at nference, where he collaborated closely with Mayo Clinic on a range of clinical research projects leveraging AI on real-world data. Dr. Wagner earned his undergraduate degree in chemical engineering from the Massachusetts Institute of Technology, and his PhD working jointly in the Weiss lab at MIT and the Densmore lab at Boston University, where he engineered RNA virus and mRNA platforms for regulated gene delivery. He furthered his expertise during a postdoctoral fellowship in the Weiss lab, focusing on in vivo regulatory strategies for RNA therapeutics.